0.8005
price up icon3.24%   0.0205
 
loading
Precedente Chiudi:
$0.78
Aprire:
$0.8
Volume 24 ore:
62,565
Relative Volume:
0.06
Capitalizzazione di mercato:
$5.69M
Reddito:
$5.75M
Utile/perdita netta:
$-38.96M
Rapporto P/E:
-0.0642
EPS:
-12.47
Flusso di cassa netto:
$-32.63M
1 W Prestazione:
-0.07%
1M Prestazione:
-47.71%
6M Prestazione:
-78.53%
1 anno Prestazione:
-88.48%
Intervallo 1D:
Value
$0.785
$0.81
Intervallo di 1 settimana:
Value
$0.74
$0.833
Portata 52W:
Value
$0.74
$20.60

Kala Bio Inc Stock (KALA) Company Profile

Name
Nome
Kala Bio Inc
Name
Telefono
781-996-5252
Name
Indirizzo
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Name
Dipendente
38
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
KALA's Discussions on Twitter

Confronta KALA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
KALA
Kala Bio Inc
0.81 5.48M 5.75M -38.96M -32.63M -12.47
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
423.50 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
638.23 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
443.90 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
824.39 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
182.24 40.44B 447.02M -1.18B -868.57M -6.1812

Kala Bio Inc Stock (KALA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-09-30 Downgrade Mizuho Outperform → Neutral
2025-09-29 Downgrade H.C. Wainwright Buy → Neutral
2025-09-29 Downgrade Ladenburg Thalmann Buy → Neutral
2025-09-08 Iniziato Mizuho Outperform
2025-07-11 Iniziato Ladenburg Thalmann Buy
2022-03-30 Downgrade JP Morgan Neutral → Underweight
2021-08-06 Downgrade JP Morgan Overweight → Neutral
2020-09-14 Downgrade Jefferies Buy → Hold
2020-07-23 Iniziato Northland Capital Outperform
2020-06-01 Ripresa Oppenheimer Outperform
2020-05-27 Reiterato H.C. Wainwright Buy
2020-03-09 Aggiornamento BofA/Merrill Neutral → Buy
2019-12-17 Downgrade BofA/Merrill Buy → Neutral
2019-03-14 Iniziato Jefferies Buy
Mostra tutto

Kala Bio Inc Borsa (KALA) Ultime notizie

pulisher
04:31 AM

Risk vs reward if holding onto KALA BIO Inc.M&A Rumor & High Win Rate Trade Tips - newser.com

04:31 AM
pulisher
03:29 AM

Real time scanner hits for KALA BIO Inc. explainedJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com

03:29 AM
pulisher
01:38 AM

Will KALA BIO Inc. stock sustain high P E ratiosMarket Performance Recap & Consistent Profit Alerts - newser.com

01:38 AM
pulisher
Nov 02, 2025

How supply chain issues affect KALA BIO Inc. stockJuly 2025 Sentiment & Community Trade Idea Sharing - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Applying Elliott Wave Theory to KALA BIO Inc.Market Growth Review & Low Drawdown Investment Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will KALA BIO Inc. outperform the marketJuly 2025 Highlights & Weekly Breakout Opportunity Watchlist - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is KALA BIO Inc. stock a contrarian buyJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Real time alert setup for KALA BIO Inc. performanceJuly 2025 Outlook & Low Risk High Win Rate Picks - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

When is the best time to exit KALA BIO Inc.2025 Performance Recap & Free Technical Confirmation Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How hedge fund analytics apply to KALA BIO Inc. stock2025 Market Sentiment & Verified Technical Trade Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What drives KALA BIO Inc stock priceUtilities Sector Analysis & Rapid Portfolio Expansion - earlytimes.in

Nov 02, 2025
pulisher
Nov 02, 2025

Is KALA BIO Inc a good long term investmentCash Flow Trends & Identify Breakout Stocks - earlytimes.in

Nov 02, 2025
pulisher
Nov 01, 2025

Chart based exit strategy for KALA BIO Inc.July 2025 Snapshot & Safe Capital Investment Plans - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

KALA BIO Inc. stock trend outlook and recovery pathJuly 2025 Short Interest & AI Enhanced Execution Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Will KALA BIO Inc. stock deliver shareholder value2025 Technical Patterns & Reliable Price Action Trade Plans - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Applying big data sentiment scoring on KALA BIO Inc.Weekly Investment Report & Fast Momentum Entry Tips - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is KALA BIO Inc. stock trading at a premium valuationMarket Risk Report & Verified Technical Trade Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

A Heavy Trading Day Sends Biotech And Finance Stocks Reeling - Finimize

Oct 31, 2025
pulisher
Oct 31, 2025

Will KALA BIO Inc. stock outperform value stocks2025 Geopolitical Influence & Verified Momentum Stock Watchlist - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Using fundamentals and technicals on KALA BIO Inc.Weekly Market Outlook & Low Risk High Win Rate Stock Picks - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Volatility clustering patterns for KALA BIO Inc.M&A Rumor & AI Optimized Trade Strategies - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Measuring KALA BIO Inc.’s beta against major indicesQuarterly Trade Review & Growth Focused Entry Reports - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Will KALA BIO Inc. stock recover after recent dropJuly 2025 EndofMonth & Fast Exit and Entry Strategy Plans - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Detecting support and resistance levels for KALA BIO Inc.Earnings Trend Report & High Conviction Investment Ideas - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Why KALA BIO Inc. stock is recommended by analystsTake Profit & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 29, 2025

Kala Bio Inc Azioni (KALA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Kala Bio Inc Azioni (KALA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Reumuth Mary
CHIEF FINANCIAL OFFICER
Oct 22 '25
Sale
0.83
32,230
26,751
29,873
Reumuth Mary
CHIEF FINANCIAL OFFICER
Oct 23 '25
Sale
0.82
967
793
28,906
Bazemore Todd
Director
Oct 22 '25
Sale
0.83
47,768
39,647
35,932
Brazzell Romulus K
SEE REMARKS
Oct 22 '25
Sale
0.83
46,748
38,801
35,952
Kharabi Darius
CHIEF BUSINESS OFFICER
Oct 22 '25
Sale
0.83
20,806
17,269
41,760
$37.33
price down icon 0.21%
$93.16
price down icon 0.32%
$28.82
price up icon 0.74%
$104.30
price up icon 0.20%
biotechnology ONC
$312.52
price up icon 0.95%
$182.24
price down icon 3.63%
Capitalizzazione:     |  Volume (24 ore):